Commentary: Mutations of transferrin receptor 2 (Trf-2) and iron storage disease

Blood Cells, Molecules, and Diseases

Volumn 27, Issue 1, 2001, Pages 294-295

  Beutler, Ernest ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CERULOPLASMIN; GENE PRODUCT; HFE PROTEIN; TRANSFERRIN; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2; UNCLASSIFIED DRUG;

GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HEMOSIDEROSIS; HUMAN; MOLECULAR CLONING; NOTE; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0035051624     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.2001.0383     Document Type: Editorial

References (7)

1. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
2. A case of ceruloplasmin deficiency which showed dementia, ataxia and iron deposition in the brain
3. Mutations in candidate genes that may influence the hemochromatosis phenotype: Transferrin receptor-1 and transferrin receptor-2
4. Mutations in candidate genes that may influence the hemochromatosis phenotype: Ferroportin and ceruloplasmin
5. Mutations in candidate gene that may influence the hemochromatosis phenotype: Transferrin
6. HLA-H and associated proteins in patients with hemochromatosis
7. Transferrin receptor mutation analysis in hereditary hemochromatosis patients